Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S/P Chemoprophylaxis for Severe Anaemia Recurrence in Gambian Children
NCT00131716Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia and malaria comparing Sulfadoxine-pyrimethamine with Placebo (2 arms). Primary endpoints: Proportion of children with moderate anaemia (Hb < 7 g/dl) and Hemoglobin concentration. Started May 2003; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
anemiamalaria
Beyond the preview
Go deeper on NCT00131716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131716.